Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Update on chronic hand eczema].
Halioua B, Richard MA; Groupe d'experts sur l'eczéma chronique des mains. Halioua B, et al. Ann Dermatol Venereol. 2010 Apr;137(4):315-27. doi: 10.1016/j.annder.2010.02.023. Epub 2010 Apr 7. Ann Dermatol Venereol. 2010. PMID: 20417371 Review. French. No abstract available.
Perceived prevalence of a sensitive scalp: A worldwide study.
Misery L, Halioua B, Skayem C, Baissac C, Inane M, Ben Hayoun Y, Saint Aroman M, Taieb C. Misery L, et al. Among authors: halioua b. J Eur Acad Dermatol Venereol. 2024 Feb;38(2):e191-e192. doi: 10.1111/jdv.19527. Epub 2023 Oct 4. J Eur Acad Dermatol Venereol. 2024. PMID: 37728529 No abstract available.
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review.
Torres T, Galván J, Crutchley N, Praestegaard M, Iversen L, Gisondi P, Carrascosa JM, Halioua B, Bewley A, Pinter A. Torres T, et al. Among authors: halioua b. Dermatol Ther (Heidelb). 2023 Oct;13(10):2153-2169. doi: 10.1007/s13555-023-01003-0. Epub 2023 Sep 23. Dermatol Ther (Heidelb). 2023. PMID: 37740858 Free PMC article. Review.
A novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD-cream demonstrates greater improvements in daily activities and personal relationships than CAL/BDP gel/TS: A post-hoc analysis of DLQI outcomes from two phase 3 placebo-controlled randomized clinical trials in mild-to-moderate psoriasis.
Halioua B, Caillet G, Taieb C, Bewley A, Snel-Prentø A, Praestegaard M, Armstrong A, Pinter A. Halioua B, et al. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):e326-e328. doi: 10.1111/jdv.19600. Epub 2023 Nov 21. J Eur Acad Dermatol Venereol. 2024. PMID: 37907283 No abstract available.
122 results